Active, not recruitingNCT05023044

Nonalcoholic Fatty Liver Disease in HIV Database

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov March 31, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Johns Hopkins University
Principal Investigator: Tinsay A Woreta, MD, MPH
Johns Hopkins University
Enrollment: 400 target
Eligibility: 18 years · All sexes
Timeline: 2022 – 2031

Study locations (8)

University of Alabama, Birmingham, Alabama, United States
University of California, San Diego, San Diego, California, United States
University of California, San Francisco, San Francisco, California, United States
Indiana University, Indianapolis, Indiana, United States
Johns Hopkins University, Baltimore, Maryland, United States
Duke University, Durham, North Carolina, United States
University of Texas, Houston, Texas, United States
Virginia Commonwealth University, Richmond, Virginia, United States

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05023044 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials